Sarah F. Smithson

Sarah F. Smithson

Auto-generated profile, based on publicly available information

Sarah F. Smithson

Bristol Medical School Translational Health Sciences, University of Bristol, Bristol, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2013 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
EWEmma Mm Burkitt Wright
Emma Mm Burkitt Wright
LPLouise Frances PORTER
Louise Frances PORTER
HSHelen L Spencer
Helen L Spencer
JCJill Clayton-Smith
Jill Clayton-Smith
LALeon Au
Leon Au
GBGraeme Black
Graeme Black
Brittle cornea syndrome (BCS) is an autosomal recessive disorder characterised by extreme corneal thinning and fragility. Corneal rupture can therefore occur either spontaneously or following minimal trauma in affected patients. Two genes, ZNF469 and PRDM5, have now been identified, in which causative pathogenic mutations collectively account for the condition in nearly all patients with BCS ascertained to date. Therefore, effective molecular diagnosis is now available for affected patients, and those at risk of being heterozygous carriers for BCS. We have previously identified mutations in ZNF469 in 14 families (in addition to 6 reported by others in the literature), and in PRDM5 in 8 families (with 1 further family now published by others). Clinical features include extreme corneal thinning with rupture, high myopia, blue sclerae, deafness of mixed aetiology with hypercompliant tympanic membranes, and variable skeletal manifestations. Corneal rupture may be the presenting feature of BCS, and it is possible that this may be incorrectly attributed to non-accidental injury. Mainstays of management include the prevention of ocular rupture by provision of protective polycarbonate spectacles, careful monitoring of visual and auditory function, and assessment for skeletal complications such as developmental dysplasia of the hip. Effective management depends upon appropriate identification of affected individuals, which may be challenging given the phenotypic overlap of BCS with other connective tissue disorders.

22 March 2017 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
KLKaren J Low
Karen J Low
MAMorad Ansari
Morad Ansari
RJRami Abou Jamra
Rami Abou Jamra
ACAngus Clarke
Angus Clarke
SCSalima El Chehadeh
Salima El Chehadeh
SSSarah F Smithson
Sarah F Smithson
PUF60 encodes a nucleic acid-binding protein, a component of multimeric complexes regulating RNA splicing and transcription. In 2013, patients with microdeletions of chromosome 8q24.3 including PUF60 were found to have developmental delay, microcephaly, craniofacial, renal and cardiac defects. Very similar phenotypes have been described in six patients with variants in PUF60, suggesting that it underlies the syndrome. We report 12 additional patients with PUF60 variants who were ascertained using exome sequencing: six through the Deciphering Developmental Disorders Study and six through similar projects. Detailed phenotypic analysis of all patients was undertaken. All 12 patients had de novo heterozygous PUF60 variants on exome analysis, each confirmed by Sanger sequencing: four frameshift variants resulting in premature stop codons, three missense variants that clustered within the RNA recognition motif of PUF60 and five essential splice-site (ESS) variant. Analysis of cDNA from a fibroblast cell line derived from one of the patients with an ESS variants revealed aberrant splicing. The consistent feature was developmental delay and most patients had short stature. The phenotypic variability was striking; however, we observed similarities including spinal segmentation anomalies, congenital heart disease, ocular colobomata, hand anomalies and (in two patients) unilateral renal agenesis/horseshoe kidney. Characteristic facial features included micrognathia, a thin upper lip and long philtrum, narrow almond-shaped palpebral fissures, synophrys, flared eyebrows and facial hypertrichosis. Heterozygote loss-of-function variants in PUF60 cause a phenotype comprising growth/developmental delay and craniofacial, cardiac, renal, ocular and spinal anomalies, adding to disorders of human development resulting from aberrant RNA processing/spliceosomal function.

12 March 2016 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PDF file
MTMadeleine Tooley
Madeleine Tooley
DLDanielle Lynch
Danielle Lynch
FBFrancois Bernier
Francois Bernier
JPJillian Parboosingh
Jillian Parboosingh
EBElizabeth Bhoj
Elizabeth Bhoj
SSSarah Smithson
Sarah Smithson
Cerebro–Costo–Mandibular syndrome (CCMS) is a rare autosomal dominant condition comprising branchial arch‐derivative malformations with striking rib‐gaps. Affected patients often have respiratory difficulties, associated with upper airway obstruction, reduced thoracic capacity, and scoliosis. We describe a series of 12 sporadic and 4 familial patients including 13 infants/children and 3 adults. Severe micrognathia and reduced numbers of ribs with gaps are consistent findings. Cleft palate, feeding difficulties, respiratory distress, tracheostomy requirement, and scoliosis are common. Additional malformations such as horseshoe kidney, hypospadias, and septal heart defect may occur. Microcephaly and significant developmental delay are present in a small minority of patients. Key radiological findings are of a narrow thorax, multiple posterior rib gaps and abnormal costo‐transverse articulation. A novel finding in 2 patients is bilateral accessory ossicles arising from the hyoid bone. Recently, specific mutations in SNRPB, which encodes components of the major spliceosome, have been found to cause CCMS. These mutations cluster in an alternatively spliced regulatory exon and result in altered SNRPB expression. DNA was available from 14 patients and SNRPB mutations were identified in 12 (4 previously reported). Eleven had recurrent mutations previously described in patients with CCMS and one had a novel mutation in the alternative exon. These results confirm the specificity of SNRPB mutations in CCMS and provide further evidence for the role of spliceosomal proteins in craniofacial and thoracic development.

16 November 2010 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
MCMorag Collinson
Morag Collinson
SLSamantha J. Leonard
Samantha J. Leonard
JCJocelyn Charlton
Jocelyn Charlton
JCJohn A. Crolla
John A. Crolla
CSCaroline Silve
Caroline Silve
SSSarah F. Smithson
Sarah F. Smithson

3 May 2012 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
SKSteven J Keogh
Steven J Keogh
SMShane McKee
Shane McKee
SSSarah F Smithson
Sarah F Smithson
DGDavid Grier
David Grier
CSColin G Steward
Colin G Steward
Background: The differential diagnosis of a neonate or fetus presenting with a bell-shaped or long narrow thorax includes a wide range of bony dysplasia syndromes. Where this is accompanied by respiratory distress, asphyxiating thoracic dystrophy (ATD, Jeune syndrome) is an important potential diagnosis. Shwachman-Diamond syndrome (SDS) is widely recognised as a cause of exocrine pancreatic dysfunction, short stature and bone marrow failure. It is not so well appreciated that rib and/or thoracic cage abnormalities occur in 30–50% of patients and that, in severe cases, these abnormalities may lead to thoracic dystrophy and respiratory failure in the newborn. There are, however, at least three previous case reports of children who were initially diagnosed with ATD who were subsequently shown to have SDS. Case presentation: This report details the case history of a patient misdiagnosed as having ATD as a neonate following the neonatal asphyxial death of her brother. She subsequently developed progressive pancytopenia but was only diagnosed with SDS at 11 years of age after referral for haematopoietic stem cell transplantation for bone marrow failure accompanied by trilineage dysplasia and clonal cytogenetic abnormalities on bone marrow examination. Subsequent testing revealed the presence of fat globules in stools, reduced faecal chymotrypsin, fat-soluble vitamin deficiency, metaphyseal dysplasia on skeletal survey and heterozygous mutations of the SBDS gene. Conclusion: This report highlights the potential for diagnostic confusion between ATD and SDS. It is important to include SDS in the differential diagnosis of newborns with thoracic dystrophy and to seek expert clinical and radiological assessment of such children.

24 November 2009 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
RHRob Hastings
Rob Hastings
DHDavid Harding
David Harding
ADAlan Donaldson
Alan Donaldson
RLRachel Liebling
Rachel Liebling
AHAlison Hayes
Alison Hayes
SSSarah Smithson
Sarah Smithson